The epigenetic alteration results in its reduced expression level, and in turn increases the expression of SH3GL1 by reducing ATF3-mediated inhibition of SH3GL1, which is a fusion partner in acute myeloid leukemia and plays a role in leukemogenesis. Here, SH3GL1 is linked to acute myeloid leukemia.